Oxcarbazepine monotherapy in postherpetic neuralgia unresponsive to carbamazepine and gabapentin

Acta Neurologica Scandinavica

Volumn 111, Issue 4, 2005, Pages 229-232

  Criscuolo, S ^a   Auletta, C ^b   Lippi, S ^a   Brogi, F ^b   Brogi, Amerigo ^a  

^a UNIVERSITY HOSPITAL OF SIENA   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

Author keywords

Allodynia; Anticonvulsants; Neuropathic pain; Oxcarbazepine; Postherpetic neuralgia

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; GABAPENTIN; OXCARBAZEPINE;

ADULT; AGED; ALLODYNIA; ARTICLE; CLINICAL ARTICLE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HUMAN; LOCAL ANESTHESIA; MALE; POSTHERPETIC NEURALGIA; QUALITY OF LIFE; VISUAL ANALOG SCALE;

ADULT; AGED; AGED, 80 AND OVER; AMINES; ANTICONVULSANTS; CARBAMAZEPINE; CYCLOHEXANECARBOXYLIC ACIDS; DRUG RESISTANCE; FEMALE; GAMMA-AMINOBUTYRIC ACID; HERPES ZOSTER; HUMANS; MALE; MIDDLE AGED; PAIN; PATIENT SATISFACTION; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 15044357367     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2005.00300.x     Document Type: Article

References (15)

1. JOHNSON RW. Consequences and management of pain in herpes zoster. J Infect Dis 2002;186(Suppl. 1):S83-90.
2. SCHMADER KE. Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy. Clin J Pain 2002;18:350-4.
3. PETER C, WATSON N, LOESER JD. Herpes zoster and postherpetic neuralgia. In: Loeser JD, Butler SH, Chapman CR, Turk DC, eds. Bonica's management of pain. Philadelphia: Lippincott Williams & Wilkins, 2002;424-32.
4. VOLMINK J, LANCASTER T, GRAY S et al. Treatments for postherpetic neuralgia: a systematic review of randomized controlled trials. Fam Pract 1996;13:84-91.
5. RICE ASC, MATON S, Postherpetic Neuralgia Study Group. Gabapentin in postherpetic neuralgia: a randomised, double blind, placebo controlled study. Pain 2001;94:215-24.
6. ROWBOTHAM M, HARDEN N, STACEY B, BERNSTEIN P, MAGNUS-MILLER L. Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. JAMA 1998;280:1837-42.
7. ZAKRZEWSKA JM, PATSALOS PN. Long-term cohort study comparing medical (oxcarbazepine) and surgical management of intractable trigeminal neuralgia. Pain 2002; 95:259-66.
8. HARDEN RN, BACKONJA M-M, NICHOLSON BD et al. Mechanistic approach to the treatment of painful neuropathies: results of a large survey of pain specialists. Poster Presented at the 21st Annual Scientific Meeting of the American Pain Society, Baltimore, MD, USA, March 14-17, 2002;808.
9. ROYAL MA, JENSON M, BHAKTAB et al. An open-label trial of oxcarbazepine in patients with complex regional pain syndrome refractory to gabapentin. Poster Presented at the 21st Annual Scientific Meeting of the American Pain Society, Baltimore, MD, USA, March 14-17, 2002;763.
10. WARD S, ROYAL M, JENSON M et al. An open-label trial of oxcarbazepine in patients with radiculopathy refractory to gabapentin. Poster Presented at the 21st Annual Scientific Meeting of the American Pain Society, Baltimore, MD, USA, March 14-17, 2002;765.
11. BEYDOUN A, KOBETZ SA, CARRAZANA EJ. Efficacy of oxcarbazepine in the treatment of painful diabetic neuropathy. Clin J Pain 2004;20:174-8.
12. CARRAZANA E, MIKOSHIBA I. Rationale and evidence for the use of oxcarbazepine in neuropathic pain. J Pain Sympt 2003;25:31-5.
13. CRISCUOLO S, AULETTA C, LIPPI S, BROGI F, BROGI A. Results of an open-label trial of oxcarbazepine monotherapy in patients with post-herpetic neuralgia refractory to both carbamazepine and gabapentin. Poster Presented at the 22nd Annual Scientific Meeting of the American Pain Society, Chicago, IL, USA, March 20-23, 2003;711.
14. ATTAL N, BOUHASSIRA D. Mechanisms of pain in peripheral neuropathy. Acta Neurol Scand Suppl 1999;173:12-24 (discussion 48-52).
15. WOOLF CJ, MANNION RJ. Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet 1999;353:1959-64.